Research

Dementia is one of the most expensive diseases in the United States, increasing healthcare costs 3 times over those without dementia. Until now, studies on the costs of different dementia […]

Every 3 years, a national research summit is held to update research strategies for non-Alzheimer’s dementias. This 2-day national event is one of 3 rotating summits held in response to […]

A study out of the U.K. revealed that people with one form of LBD, specifically, dementia with Lewy bodies and more frequently admitted to general hospitals that people with Alzheimer’s […]

A new study reveals family caregivers have an increase in the beneficial stress hormone DHEA-S on days when they use an adult day service for their relatives with dementia. DHEA-S […]

REM sleep behavior disorder (RBD) is a condition that causes a person to physically act out their dreams and is a common in Lewy body dementia (LBD). RBD is a […]

The combination of cognitive, motor and behavioral symptoms early in the course of LBD creates a highly challenging set of demands for continuing care. Recent studies demonstrate that LBD families […]

In December ACADIA Pharmaceuticals presented its top-line results from its Phase 3 clinical trial of pimavanserin in people who had dementia-related psychosis. The results had been eagerly awaited; ACADIA stopped […]

Because Lewy body dementia is the most misdiagnosed form of dementia, LBDA developed a useful checklist to help physicians and their patients identify key LBD symptoms used to make a […]

People who have LBD plus changes in the brain associated with Alzheimer’s disease tend to have more aggressive disease progression. However, science has not yet explained why these two disease […]

The human genome is a complete set of a person’s DNA. Serving as a blueprint for all cells in the body, the genome contains about 20,000 genes. The first human […]